Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,907,224,662
+$98,040,268 QoQ
Shares Held
20,075,375
-13.6% QoQ
Ownership
0.834%
of shares outstanding
% of Portfolio
0.93%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 98.85025310859697.ToString("F0")%
None 1.1497468914030249.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $38,477,015,517 across 12 Drug Manufacturers - General names. JNJ ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,427,061 | $12,349,807,890 | |
| 2 | MRK |
Merck & Co., Inc.
|
84,314,971 | $10,142,247,857 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
20,075,375 | $4,907,224,662 | |
| 4 | AZN |
Astrazeneca PLC
|
23,751,085 | $4,684,188,978 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,537,991 | $1,886,789,800 | |
| 6 | ABBV |
AbbVie Inc.
|
6,897,816 | $1,500,205,997 | |
| 7 | PFE |
Pfizer Inc
|
49,916,961 | $1,401,668,262 | |
| 8 | GSK |
GSK plc
|
11,717,613 | $646,695,059 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,907,224,662 | 20,075,375 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,809,184,394 | 23,238,388 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,789,913,506 | 25,832,777 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,799,891,178 | 24,876,538 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,755,606,167 | 22,645,961 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,522,447,438 | 24,356,572 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $3,877,344,973 | 23,925,367 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,631,983,184 | 24,849,365 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,756,532,865 | 23,746,968 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,764,851,694 | 24,019,725 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $3,212,821,588 | 20,628,068 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,799,650,634 | 22,955,840 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,934,950,125 | 25,386,775 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,745,016,669 | 26,861,119 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,571,946,352 | 27,986,939 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,242,094,312 | 29,531,262 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,808,286,830 | 32,772,594 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,561,017,650 | 32,507,264 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,208,462,370 | 32,250,541 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,425,675,323 | 32,934,778 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $5,569,190,722 | 33,886,162 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,575,063,268 | 35,424,217 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $5,028,053,220 | 33,772,523 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,045,924,394 | 28,769,995 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,006,895,084 | 30,556,662 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||